• +598 29008192
  • info@servinfo.com.uy

The FDA Announces Two More Antacid Recalls Due to Cancer Risk

The FDA Announces Two More Antacid Recalls Due to Cancer Risk

Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.
Source: Wired

Belen De Leon